Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas

Clinical Trial ID NCT01794104

PubWeight™ 2.41‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01794104

Top papers

Rank Title Journal Year PubWeight™‹?›
1 DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem 2001 12.53
2 Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol 2002 11.79
3 Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 2006 9.15
4 Plasma pharmacokinetics of the indenoisoquinoline topoisomerase I inhibitor, NSC 743400, in rats and dogs. Cancer Chemother Pharmacol 2015 0.87
5 Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines. BMC Cancer 2016 0.79
6 Synthesis and biological evaluation of new fluorinated and chlorinated indenoisoquinoline topoisomerase I poisons. Bioorg Med Chem 2016 0.75
Next 100